Story thread · 2 reports / 2 sources
Keros Therapeutics launches $5M share buyback after $20M milestone
seekingalpha.com · 6d
First report: Protagonist Therapeutics authorizes $300 million buyback plan — investing.com, 6d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.